| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05a203d85ee01909eaf728dc16f0f6cb |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6867
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6807
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-704 |
| filingDate |
2018-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2020-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eba58fe2bc8a738c10f3388ea9e41873
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b16449a195e8b8c9a299e56bfedbce0a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a7056dd1ffb376e1559333550db1a57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a374dab69b931cb22c3d60c3aec283ad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b083ff3322e9197d3c1d91a26810a5b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45b05bc54735e3024d26477cb2dbb3ce
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b11c303649f365a3108a7e930a4ab52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0564aa51f49240eb27f5b661b9e261fb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b6005a14c06ea238b631c8a612857ee4 |
| publicationDate |
2020-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-I687221-B |
| titleOfInvention |
Calicheamicin derivatives and antibody drug conjugates thereof |
| abstract |
The present invention is directed to novel calicheamicin derivatives useful as payloads in antibody-drug-conjugates (ADC's), and to payload-linker compounds and ADC compounds comprising the same; to pharmaceutical compositions comprising the same and to methods for using the same to treat pathological conditions such as cancer. |
| priorityDate |
2017-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |